We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

33 hedge funds and large institutions have $21.2M invested in Abeona Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

5.08% less ownership

Funds ownership: 47.58% → 42.5% (-5.1%)

20% less funds holding

Funds holding: 41 → 33 (-8)

25% less capital invested

Capital invested by funds: $28.5M → $21.2M (-$7.24M)

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

Holders
33
Holders Change
-8
Holders Change %
-19.51%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$3.02M
2
WSL
Western Standard LLC
California
+$586K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$433K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$373K
5
Northern Trust
Northern Trust
Illinois
+$88.1K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$3.41M
2
EC
EcoR1 Capital
California
-$3.35M
3
ACM
Altium Capital Management
New York
-$335K
4
XT
XTX Topco
Cayman Islands
-$160K
5
Jane Street
Jane Street
New York
-$115K
Name Holding Trade Value Shares
Change 		Change in
Stake
HFM
26
Hartford Financial Management
Connecticut
$2.11K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$2K -$41.9K -16,044 -96%
JP Morgan Chase
28
JP Morgan Chase
New York
$2K +$1.84K +704 +5,029%
PA
29
Parallel Advisors
California
$1.13K – – –
Wells Fargo
30
Wells Fargo
California
$319 +$167 +64 +131%
TC
31
Truvestments Capital
Florida
$144 – – –
CT
32
Cambridge Trust
Massachusetts
$37 – – –
2L
33
25 LLC
Missouri
$16 +$13 +5 New
AC
34
Armistice Capital
New York
– -$3.41M -1,106,000 Closed
EC
35
EcoR1 Capital
California
– -$3.35M -1,086,956 Closed
ACM
36
Altium Capital Management
New York
– -$335K -108,696 Closed
XT
37
XTX Topco
Cayman Islands
– -$160K -51,888 Closed
Jane Street
38
Jane Street
New York
– -$115K -37,401 Closed
DFCM
39
Dark Forest Capital Management
Puerto Rico
– -$8.51K -2,764 Closed
Rockefeller Capital Management
40
Rockefeller Capital Management
New York
– -$4K -1,500 Closed
UBS Group
41
UBS Group
Switzerland
– -$2.98K -967 Closed
IA
42
IFP Advisors
Florida
– -$2K -400 Closed
MCC
43
Money Concepts Capital
Florida
– -$616 -200 Closed
Bank of America
44
Bank of America
North Carolina
– -$98 -32 Closed
GRP
45
Global Retirement Partners
California
– -$18 -6 Closed
1
2

ABEO Hedge Fund Activity: Q1 2023 in Review

33 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2023, worth a combined $21.2M — down 25% from $28.5M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ABEO and 4 opened new positions — a net loss of 8 holders — while 6 trimmed existing stakes and 10 added.

The largest buyer was Nantahala Capital Management, adding an estimated $3.02M. The largest seller was Armistice Capital, exiting entirely with an estimated $3.41M sold.

  • 33 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2023, down from 41 in Q4 2022.
  • Funds reported $21.2M of Abeona Therapeutics stock for Q1 2023, down 25% quarter-over-quarter.
  • 4 funds opened new Abeona Therapeutics positions in Q1 2023 and 12 closed out, a net change of -8 holders.
  • The largest Abeona Therapeutics buyer in Q1 2023 was Nantahala Capital Management, an estimated $3.02M added.
  • The largest Abeona Therapeutics seller in Q1 2023 was Armistice Capital, an estimated $3.41M sold.

Based on aggregated 13F filings for Q1 2023.